🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
SARS-CoV-2 infection seems to induce in most critical cases an excessive an...
Status
Unknown
Location
ICU- University Hospital Modena
Start Date
2020-11-25
Trial ID
NCT04528888
Treatments Being Tested
In an open-label parallel groups blinded-endpoint randomized clinical trial...
Status
Terminated
Location
Rajaie Cardiovascular Medical and Research Center
Start Date
2018-12-22
Trial ID
NCT05172115
A three-arm randomized controlled non-inferiority pilot study comparing ant...
Status
Recruiting
Location
Medical University of Vienna
Start Date
2024-07-30
Trial ID
NCT06442267
Treatments Being Tested
1. INTRODUCTION Through last couple of years the number of patients tre...
Status
Completed
Location
Albert Einstein College of Medicine
Start Date
2005-01
Trial ID
NCT01863134
Treatments Being Tested
The purpose of this study is to find out if treating multiple myeloma (MM) ...
Status
Completed
Location
University of Arkansas for Medical Sciences
Start Date
2003-12
Trial ID
NCT00113932
Treatments Being Tested
The purpose of this study is to determine if additional interventions will ...
Status
Enrolling By Invitation
Location
University of Colorado
Start Date
2023-09-27
Trial ID
NCT05794165
Treatments Being Tested
This study was to compare the study drug BAY1213790 to existing therapies, ...
Status
Completed
Location
UMHAT Sveti Georgi
Start Date
2017-09-21
Trial ID
NCT03276143
Treatments Being Tested
RATIONALE: Sometimes the cancer may not need treatment until it progresses....
Status
Withdrawn
Location
Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
Start Date
2008-09
Trial ID
NCT00723658
This study is aiming to test the hypothesis that efficacy of rhTNK-tPA was ...
Status
Completed
Location
Guangzhou Recomgen Biotech Co., Ltd.
Start Date
2016-05
Trial ID
NCT02835534
This study aims first to assess the efficacy, safety, and effectiveness of ...
Status
Unknown
Location
SZUMC
Start Date
2020-03-28
Trial ID
NCT05925140